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SUMMARY
The appropriate execution of DNA double-strand
break (DSB) repair is critical for genome stability
and tumor avoidance. 53BP1 and BRCA1 directly
influence DSB repair pathway choice by regulating
50 end resection, but how this is achieved remains
uncertain. Here we report that Rif1/ mice are
severely compromised for 53BP1-dependent class
switch recombination (CSR) and fusion of dysfunc-
tional telomeres. The inappropriate accumulation of
RIF1 at DSBs in S phase is antagonized by BRCA1,
and deletion of Rif1 suppresses toxic nonhomolo-
gous end joining (NHEJ) induced by PARP inhibition
in Brca1-deficient cells. Mechanistically, RIF1 is re-
cruited to DSBs via the N-terminal phospho-SQ/TQ
domain of 53BP1, and DSBs generated by ionizing
radiation or during CSR are hyperresected in the
absence of RIF1. Thus, RIF1 and 53BP1 cooperate
to block DSB resection to promote NHEJ in G1,
which is antagonized by BRCA1 in S phase to
ensure a switch of DSB repair mode to homologous
recombination.
INTRODUCTION
DNA double-strand breaks (DSBs) are highly toxic lesions that
form when both strands of the DNA duplex are disrupted simul-
taneously. DSBs arise following exposures to ionizing radiation
(IR) and spontaneously as a result of problems encountered
during DNA replication that trigger replication fork collapse
(Pfeiffer et al., 2000). However, DSBs can also be programmed
and are essential during meiosis for promoting exchange
between homologous chromosomes to generate genetic diver-
sity and to ensure correct chromosome segregation at meiosis I
(Youds and Boulton, 2011). The repair of programmed DSBs is
also essential for the production of a full immune repertoire
during V(D)J recombination and class switch recombination
(CSR) (Stavnezer et al., 2008). DSBs also exist at the end of all
linear chromosomes but are normally protected by the telomere
and its binding proteins from erroneous repair (de Lange, 2005).
Failure to correctly repair DSBs or defects in telomere mainte-
nance have been linked to numerous genetic disorders associ-
ated with genome instability, cancer predisposition, accelerated
aging, and immune deficiency (Jackson and Bartek, 2009;
McKinnon, 2009).
To counter the potential deleterious impact of DSBs, cells
have evolved distinct DSB repair pathways, of which nonhomol-
ogous end joining (NHEJ) and homologous recombination (HR)
are the best understood in eukaryotic cells. NHEJ is a DSB
rejoining mechanism that is active throughout the cell cycle but
is preferred in G1. NHEJ ensures that broken DSB ends are
held in close proximity to permit their direct ligation. As NHEJ
operates independently of DNA sequence, it is intrinsically error
prone and can drive chromosome translocations by joining
DSBs from different parts of the genome (Elliott and Jasin,
2002; Lieber, 2010). In contrast, HR is a largely error-free mech-
anism of DSB repair that is primarily active in S and G2 cell cycle
phases, which requires an intact homologous duplex sequence
as a repair template (West, 2003). The initial processing of the
DSB ends is a key determinant of DSB repair pathway choice
and is tightly regulated during the cell cycle (Symington and
Gautier, 2011). In the G1 cell-cycle phase, DSBs are protected
to limit DNA end resection, which favors repair by NHEJ.
However, upon entry into S phase, DSB end protection is
relieved and 50 end resection is activated to produce DSBs
with a 30 single-stranded overhang, which is the preferred sub-
strate for repair by HR (Symington and Gautier, 2011; West,
2003).
53BP1 is a key DNA repair factor that plays a pivotal role in
defining DSB repair pathway choice in G1 and S/G2 cell-cycle
phases (Chapman et al., 2012b). Emerging evidence suggests
that 53BP1’s association with DSBs in G1 promotes NHEJ by
suppressing the inappropriate 50 resection of DSBs (Bothmer
et al., 2010, 2011). As cells enter S phase, the barrier to DSB
resection mediated by 53BP1 is alleviated by the action of
BRCA1, which drives the removal of 53BP1 from DSBs in
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S/G2, thus allowing resection and error-free repair by homolo-
gous recombination (Bunting et al., 2010; Chapman et al.,
2012a). A clear illustration of the antagonistic relationship
between 53BP1 and BRCA1 is seen in mouse models, where
the embryonic lethality, tumor predisposition, and HR defect of
Brca1-deficient mice can be rescued by deleting 53BP1 (Bouw-
man et al., 2010; Bunting et al., 2010; Cao et al., 2009). Based on
these observations, it is believed that the defects associated
with Brca1 deficiency reflect an inability to counteract 53BP1-
dependent toxic NHEJ in S/G2.
In addition to playing a central role in promoting NHEJ in G1,
53BP1 function is also essential for the establishment of a func-
tional immune systemduring CSR and is responsible for the erro-
neous fusion of dysfunctional telomeres (Dimitrova et al., 2008;
Manis et al., 2004; Ward et al., 2004). During CSR, activation-
induced cytidine deaminase (AID) is essential for the production
of DSBs within switch regions located in the immunoglobulin
heavy chain (IgH) locus (Neuberger et al., 2003; Pavri and
Nussenzweig, 2011). The assembly of antibodies of different
class requires that AID-induced DSBs are subject to dele-
tional repair through classical and alternative NHEJ pathways
(Stavnezer et al., 2008; Yan et al., 2007). Loss of 53BP1 confers
the most severe CSR defect of the DNA repair factors implicated
in this process and results in a dramatic decrease in CSR-
dependent antibody classes to levels less than 10% of wild-
type (WT) (Manis et al., 2004; Ward et al., 2004).
The 53BP1 protein comprises homo-oligomerization and
tandemTudor domains that cooperatively mediate its accumula-
tion at DSB sites via interactions with the H4-K20me2 histone
epitope, an extended N terminus containing an abundance of
ATM-target SQ/TQ sites, a glycine-arginine rich (GAR) domain
permitting PRMT-dependent methylation, and C-terminal
BRCT domains that likely mediate phospho-protein interactions
(Chapman et al., 2012b). While the GAR and BRCT domains are
largely dispensable for 53BP1’s role in DNA repair, the Tudor,
oligomerization, and N-terminal SQ/TQ phospho-site domains
are essential for 53BP1-dependent inhibition of DSB hyperre-
section of DSBs induced during CSR and V(D)J recombination
(Bothmer et al., 2011; Difilippantonio et al., 2008). Importantly,
the same 53BP1 domains have been implicated in driving toxic
NHEJ in Brca1-deficient cells and for promoting fusion of
dysfunctional telomeres (Bothmer et al., 2011; Rai et al., 2010).
Of these domains, the function of the N-terminal SQ/TQ phos-
pho-site domain remains the least well understood.
Rif1 was first identified in budding yeast where it negatively
regulates telomere length homeostasis via interaction with the
C-terminal domain of Rap1 (Hardy et al., 1992; Marcand et al.,
1997; Wotton and Shore, 1997). Although there is no clear
evidence that the telomere role is conserved in higher eukary-
otes, Rif1 has been implicated in a wide variety of other cellular
processes, including the intra-S phase checkpoint, timing of
replication origin firing, and replication of heterochromatin
(Buonomo et al., 2009; Cornacchia et al., 2012; Silverman
et al., 2004; Yamazaki et al., 2012). Moreover, Rif1 gene disrup-
tion in mice is lethal, yielding developmental defects in early
embryogenesis (Buonomo et al., 2009). Based on analysis of
conditional knockout Rif1/ cells, it was proposed that the
embryonic developmental defects likely reflect important roles
during S phase. Indeed, RIF1 is recruited to a subset of stalled
replication forks in a manner dependent on both ATR and
53BP1, and in its absence, cells accumulate DNA damage
during S phase (Buonomo et al., 2009).
Here, we report that Rif1-deficient mice are viable in a CD1
genetic background, yet are immune-compromised due to
CSR defects comparable in severity to that observed in 53BP1
null mice. RIF1 is also essential for 53BP1-mediated fusion of
dysfunctional telomeres and drives toxic NHEJ in Brca1-
deficient cells. We further demonstrate that RIF1 functions in
the same genetic pathway as 53BP1 and show that the ATM-
dependent phosphorylation of 53BP1 promotes 53BP1-RIF1
interactions, recruiting RIF1 to DSB sites. Finally, we find RIF1
suppresses 50 end resection at DSBs induced by IR and upon
CSR. Thus, our findings uncover a key DSB repair role for RIF1
in 53BP1-dependent NHEJ, which has important ramifications
for understanding DSB pathway choice and BRCA1’s tumor-
suppressive functions.
RESULTS
Generation of RIF1-Deficient Mice
RIF1 is the only damage response factor whose recruitment to
DSBs strictly depends on 53BP1 (Silverman et al., 2004).
However, the function of RIF1 downstream of its recruitment to
DSBs by 53BP1 remains unexplored. To investigate the function
of RIF1,wegeneratedRif1mutantmice fromaGenetrap ESC line
(XT278) that harbors an integration event in intron 7 of the Rif1
gene that removes more than 90% of the RIF1 protein-coding
sequence (Figure S1A). Consistent with previous findings (Buo-
nomo et al., 2009), the Rif1XT278 mutation resulted in embryonic
lethality in inbred 129/Ola and outbredMF1mouse strains (Table
S1); E7.5 Rif1XT278/XT278 homozygous embryos (now referred
to as Rif1/) exhibited significant developmental retardation
(Figure S1B) and produced no live Rif1/ offspring (Table S1).
Rif1/ E13.5 embryos with developmental features indistin-
guishable from WT embryos were observed when the Rif1XT278
allele was crossed into the outbred CD1 strain. Moreover,
MEFs derived from Rif1/ embryos were viable in culture and
expressed no detectable RIF1 protein (Figures S1C and S1D).
Strikingly, CD1 Rif1/ progeny were also viable, yet only sub-
Mendelian numbers of male offspring were observed, indicating
that RIF1 deficiency confers female-specific lethality in this
background (Table S1). The viability of male Rif1/ progeny
presented an opportunity to study the impact of RIF1 deficiency
in mice.
Surprisingly, viable Rif1/ males grow to adulthood, are
fertile, and do not exhibit any obvious behavioral or develop-
mental abnormalities. However, the health of some of theRif1/
animals deteriorated rapidly as a result of infections of the
commensal bacteria Staphylococcous xylosus. Such infections
have been reported to affect immune-compromised mice (Go-
zalo et al., 2010), raising the possibility that RIF1 deficiencymight
manifest in a suboptimal immune response. The propensity of
male Rif1/ mice to succumb to infection, coupled to the fact
that 53BP1-deficient mice are immune-compromised due to
a severe defect in CSR (Manis et al., 2004; Ward et al., 2004),
prompted us to examine the immune status of Rif1/ mice.
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Normal Lymphocyte Development in Rif1–/– Mice
To explore the status of the immune system of Rif1/ mice,
bone marrow B cell populations of Rif1/ mice and WT litter-
mates were examined. Notably, no major differences in B cell
precursors (pro- and pre-B cells), immature, or mature B cells
were evident between WT and Rif1/mice (Figure S2A). Similar
analyses of splenocytes revealed no detectable abnormalities in
the proportion of B and T cells (Figure S2B), with no significant
differences in the percentage of follicular B cells (B220+
CD21CD23+) or marginal zone B cells (B220+CD21+CD23low;
Figure S2C). Furthermore, no substantial differences were
observed in the percentage of immature splenic B cells on the
basis of IgM and IgD expression (Figure S2C). Similarly, analyses
of T cell populations both in thymus and spleen showed similar
proportions of CD4+ and CD8+ cells in WT and Rif1/mice (Fig-
ure S2D). Hence, lymphocyte development appears largely
normal in Rif1/ mice.
RIF1 Is Essential for Class Switch Recombination
in Mice
Next we investigated the status of CSR in Rif1/ mice by
comparing the levels of serum immunoglobulins (Igs) to those
of WT animals. As shown in Figure 1A, while no differences
were detected in the levels of IgM, the concentrations of IgA
and all IgG isotypes were reduced in Rif1/ mice, suggesting
a possible contribution of RIF1 to CSR. To examine whether
such IgG/IgA reductions arise from intrinsic CSR defects, B cells
isolated fromRif1/ andWTmicewere stimulatedwith lipopoly-
saccharide (LPS) or anti-mouse CD40 in the presence or
absence interleukin 4 (IL-4). CSR proficiency was then assessed
by analysis of both cell surface Ig expression and Ig secretion
following stimulation (Figures 1B–1D). As indicated, Rif1/
cultures exhibited 90% reductions in the proportion of IgG
positive B cells when compared toWT (Figures 1B and 1C). Simi-
larly,Rif1/B cells were also severely defective in their capacity
to secrete IgG, as judged by ELISA (Figure 1D). Importantly,
proliferation rates and apoptotic and cell-cycle indices were
found to be comparable between WT and Rif1/ lymphocytes
upon stimulation (Figures 1E, S2E, and S3A). Consistent with
a recent report (Cornacchia et al., 2012), replication fork rates
and interorigin distances were also comparable between WT
and Rif1/ cells (Figure S3B).
To further analyze the role of RIF1 in CSR in vivo, Rif1/mice
and WT littermates were immunized with the antigen NP-KLH.
NP-specific Igs were measured in the serum of these animals
over time (Figure 1F). Importantly, while WT and RIF1-deficient
mice showed similar levels of NP-specific IgM, Rif1/ mice
exhibited a severe reduction in the NP-specific IgGs (Figure 1F).
To our knowledge the phenotype of Rif1/ mice is comparable
in severity only to the CSR defect previously reported for
53BP1 deficiency (Manis et al., 2004; Ward et al., 2004). Thus,
our data reveal that, like 53BP1, RIF1 is essential for productive
CSR in mice.
Rif1 Promotes NHEJ of Dysfunctional Telomeres
The similarity of the CSR defect in RIF1- and 53BP1-deficient
mice raised the possibility that RIF1 may also function in other
53BP1-dependent processes. In a pathological context, 53BP1
promotes NHEJ between distally positioned telomeres following
deprotection by shelterin component disruption (Dimitrova et al.,
2008). To determine if RIF1 also facilitates 53BP1-dependent
NHEJ events at dysfunctional telomeres, we overexpressed
the dominant-negative TRF2DBDM allele of the shelterin compo-
nent TRF2, which results in telomere deprotection and chromo-
some end-to-end fusions by NHEJ (Smogorzewska et al., 2002;
van Steensel et al., 1998). Metaphases were prepared from WT,
Rif1/, and 53Bp1/ MEFs induced to express TRF2DBDM or
TRF2 transgenes (Figure 2A) and scored for chromosome end-
to-end fusions. In WT cells, overexpression of TRF2DBDM, but
not TRF2, induced the fusion of 35% of all chromosome ends
analyzed (Figures 2B and 2C). Consistent with previous reports,
53BP1 deficiency resulted in a dramatic suppression of end-to-
end fusion events at telomeres induced by TRF2DBDM expression
(Figures 2B and 2C) (Dimitrova et al., 2008; Rai et al., 2010).
Remarkably, RIF1 deficiency also suppressed chromosome
joining events, limiting end-to-end fusion to less than 8%of chro-
mosome ends (compared to 35% seen in WT cells and 5% seen
in 53Bp1/ cells; Figures 2B and 2C). These data further
suggest that RIF1 functions in 53BP1-dependent NHEJ events.
BRCA1 Antagonizes RIF1-Dependent NHEJ during
S Phase
BRCA1 is believed to antagonize 53BP1-dependent end joining
in S phase to promote repair by HR (Bouwman et al., 2010;
Bunting et al., 2010, 2012). In agreement with these findings,
human 53BP1 and BRCA1 are found to occupy associated yet
mutually exclusive chromatin subcompartments at DSB sites,
with 53BP1 exclusion from such sites occurring in a BRCA1-
dependent manner during S phase (Chapman et al., 2012a). To
assess if a similar relationship exists between RIF1 and BRCA1,
HeLa cells treated with control and Brca1 short-interfering RNA
(siRNA) were subjected to pulse-labeling with the nucleotide
analog EdU immediately before IR, to enable accurate cell-cycle
positioning of cells counterstained for RIF1. In addition, Cyclin A
counterstaining enabled the discrimination of G1 (EdU-negative)
from G2 cell-cycle phases (EdU-negative, Cyclin A-positive).
Using this approach we found that in control-depleted cells,
RIF1 IR-induced foci (IRIF) are significantly reduced in intensity
during S phase when compared to cells in G1 or G2 cell-cycle
phases (Figures 3A and 3B). In contrast, the downregulation of
RIF1 IRIF in S phase cells was compromised uponBRCA1 deple-
tion, as evident from the intensity of RIF1 IRIF in G1 and S phase
cells, which were not significantly different (Figures 3A and 3B).
Moreover, the intensity of S and G2 phase RIF1 IRIF were signif-
icantly increased in BRCA1-depleted cells when compared with
control cells (Figure 3B), and similar results were obtained with
a second Brca1 siRNA (Figure S4A). These data indicate RIF1
IRIF are specifically suppressed during S and G2 cell-cycle
phases in a BRCA1-dependent manner.
Next, we used lentiviruses to introduce control or two different
Brca1 shRNA expression constructs into MEFs to examine the
effect of RIF1 loss on the cellular phenotypes associated with
BRCA1 deficiency. Both Brca1 shRNAs effectively depleted
BRCA1 protein in MEFs of all genotypes (Figure 3B). As ex-
pected, the expression of either Brca1 shRNA strongly reduced
proliferation rates in WT cells relative to control knockdowns.
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In contrast, RIF1 or 53BP1 deficiency significantly improved the
proliferation of cells expressing each Brca1 shRNA to similar
extents (Figure S4B).
BRCA1-deficient cells are hypersensitive to poly(ADP-ribose)
polymerase (PARP) inhibitors (PARPi), which trigger the forma-
tion of replication-associated DNA damage that requires HR for
its resolution (Bryant et al., 2005; Farmer et al., 2005; Helleday,
2011). 53BP1 loss has been shown to suppress both sponta-
neous and PARPi-induced radial chromosome formation
in BRCA1-deficient cells (Bunting et al., 2010). To determine if
RIF1 also influences the levels of spontaneous and PARPi-
induced genomic instability in BRCA1-depleted cells, we ana-
lyzed radial chromosomes in metaphase spreads. Radial chro-
mosomes were undetectable in WT untreated control-depleted
A
E
F
B
DC
Figure 1. Defective CSR in RIF1-Deficient Mice
(A) Quantification of immunoglobulins in the serum of Rif1+/+ and Rif1/ mice.
(B–D) Flow cytometry staining (B) and quantifications of surface expression (C) and secreted (D) IgG1 and IgG2b in Rif1
+/+ and Rif1/ B cells stimulated with LPS
or anti-mouse CD40 in the presence or absence of IL-4.
(E) B cells were labeled with CTV and cultured for 3 days with anti-mouse CD40 and IL-4 (black line). Grey profile, unstimulated control. Numbers of cell divisions
are depicted on the top of the graphs.
(F) Rif1+/+ and Rif1/mice were immunized with NP-KLH, and NP-specific IgM (left) and IgG (middle) were measured in mice serum at different time points after
immunization. Anti-NP-specific antibodies are shown for Rif1+/+ and Rif1/ mice at 21 days after immunization (right). Error bars are ± SEM. See also Figures
S1–S3 and Table S1.
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cells (Figure 3D). In contrast,Brca1 shRNA induced the formation
of spontaneous radial chromosomes in WT cells, which were
greatly enhanced by treatment with the PARP inhibitor Olaparib
(Figure 3D). Strikingly, RIF1 deficiency exerted a statistically
significant suppression of this phenotype, averting the formation
of both spontaneous and Olaparib-induced radial chromosomes
in Brca1-depleted cells to levels similar to that observed in
53BP1-deficent cells (Figure 3D). Thus, like 53BP1, RIF1 contrib-
utes to the toxic NHEJ events that drive genome instability in
BRCA1-deficient cells.
Impaired DSB Repair in Rif1-Deficient Cells
To examine a potential role for RIF1 in IR-induced DSB repair,
WT and Rif1/ MEFs were harvested at multiple time points
following IR treatment and imaged for 53BP1 and the DSB
marker gH2AX by indirect immunofluorescence. In both WT
and Rif1/ cells, gH2AX was apparent as early as 3 min
following IR and appeared indistinguishable at earlier time points
and up to 8 hr following IR (Figure 4A and data not shown). By
24 hr following IR, the majority of gH2AX foci had been resolved
in WT cells; however, multiple gH2AX foci persisted in Rif1/
cells at this time point (Figures 4A and 4B). Persistent 53BP1
IRIF were also observed in Rif1/ cells, with foci appearing sig-
nificantly reduced in intensity at all time points when compared
to WT cells imaged under identical conditions (Figure 4A). It is
notable that the defect in gH2AX resolution in Rif1/ cells is
similar to that reported in 53BP1-deficient MEFs (Noon et al.,
2010; Ward et al., 2006).
To examine the DSB repair defect in more detail, spontaneous
and IR-induced gH2AX IRIF were scored in WT and Rif1/ cells
incubated in the presence and absence of an ATM inhibitor
(ATMi) (Figure 4B). Strikingly, WT cells subjected to lower IR
doses (2.5 Gy) exhibited gH2AX IRIF levels onlymarginally higher
than control cells, while Rif1/ cells showed levels equivalent to
WT cells pretreated with ATMi (Figure 4B). Similar correlations in
BA
C
Figure 2. A Requirement for RIF1 in the
NHEJ of Dysfunctional Telomeres
(A) Western blot showing comparable expression
of indicated Trf2 transgenes between MEF lines of
the indicated genotype.
(B) Metaphases were analyzed for telomere end-
to-end fusions in cells of indicated genotype, 96 hr
following retroviral transduction of the indicated
TRF2 expression constructs. Right panels show
enlargement of corresponding left panel. Telo-
meric fluorescence in situ hybridization (FISH),
red; 4,6-diamidino-2-phenylindole (DAPI), gray.
(C) Quantification of chromosome fusions.
n = 3,000, 2,000, and 3,000 chromosomes scored
per genotype, over two independent experi-
ments. ***p < 0 .0001 (one-way ANOVA). Error bars
are ± SEM.
gH2AX IRIF levels between Rif1/ and
ATMi-treated WT cells were also evident
at 5 Gy IR doses (Figure 4B). Moreover,
ATMi treatments had minimal impact
on gH2AX resolution at lower IR doses
in Rif1/ cells, suggesting an epistatic relationship between
ATM and RIF1 during DSB repair. However, ATMi synergized
with Rif1 deficiency at higher doses, indicating that ATM likely
contributes to additional repair functions that aremore important
in RIF1 deficient cells with higher levels of DNA damage.
We next assessed the relative IR sensitivities of WT, Rif1/,
53Bp1/, and Rif1/53Bp1/ double-knockout MEFs in
colony survival assays. Consistent with siRNA-knockdown
experiments in human cells (Silverman et al., 2004), Rif1/
MEFs were IR hypersensitive (Figures 4C and S5A), yet this
was significantly enhanced relative to that of 53Bp1/ MEFs
(Figure 4C). However, the IR sensitivity Rif1/53Bp1/ MEFs
was not dissimilar from Rif1/ cells (Figure 4C), indicating that
although 53BP1 and RIF1 likely function in the same pathway
during DSB repair, RIF1 may have additional roles in DNA
damage responses, consistent with previous observations
(Buonomo et al., 2009; Xu et al., 2010).
Impaired NHEJ in Rif1-Depleted Cells
To directly assess if RIF1 functions to promote 53BP1-depen-
dent DSB repair by NHEJ, we employed an established DSB
reporter assay in HEK293 cells that measures NHEJ-mediated
repair between two tandem I-SceI sites (Bennardo et al., 2008).
As expected, siRNA-mediated 53BP1 depletion resulted in
a defect in NHEJ-mediated repair (Figures 4D andS5B). Remark-
ably, RIF1 downregulation with three different RIF1 siRNAs
yielded very similar NHEJ defects to 53BP1-depleted cells (Fig-
ure 4D).Moreover, codepletion of 53BP1 andRIF1 did not further
enhance NHEJ defects over single knockdowns (Figure 4D),
strongly suggesting 53BP1 and RIF1 cooperate during NHEJ.
RIF1 Recruitment to DSB Sites Requires N-Terminal
53BP1 Phospho-Domain
53BP1 contains closely opposed homo-oligomerization and
tandem Tudor domains that are both required for its interaction
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Figure 3. RIF1 Deficiency Suppresses Proliferation and Genome Instability Defects in BRCA1-Depleted Cells
(A) HeLa cells were treated with the indicated siRNA for 48 hr. Cells were then pulse-labeled with EdU (5 min, 40 mM) immediately before irradiation (5 Gy). One
hour following IR, cells were fixed and permeabilized before fluorescent labeling of EdU and counterstaining with indicated antisera. Representative projection
images of whole-nuclei 0.5 mm confocal z series are presented.
(B) Enlarged S phase images of RIF1 IRIF from (A) and automated quantification of the intensity of RIF1 IRIF in HeLa cells subjected to control or BRCA1-targeting
siRNA. n > 140 cells per condition; ***p < 0.0001, ns1 p = 0.514, ns2 p = 0.1172, ns3 p = 0.1390, Mann-Whitney test.
(C) Western blot shows comparable BRCA1-depletion efficiency between MEF lines selected for expression of indicated shRNA constructs. C, control shRNA
vector; 1, Brca1 shRNA vector 1; 2, Brca1 shRNA vector 2.
(D) Radial chromosomes were scored in metaphases prepared fromWT, Rif1/, and 53Bp1/ cell lines expressing the indicated shRNA following 16 hr control
or olaparib (1 mM) treatments. n = 50 metaphase per condition. Error bars are ± SEM. See also Figure S4.
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with nucleosomes at DSB sites (Botuyan et al., 2006; Huyen
et al., 2004; Zgheib et al., 2009). However, the contribution of
these domains, its extended N terminus, and C-terminal BRCT
motifs in promoting RIF1 recruitment are not known. To investi-
gate the 53BP1 domain requirements for RIF1 IRIF, we created
multiple stably transduced 53Bp1/ MEF lines, each express-
ing one of a series of 53BP1 mutants (Figures 5A, 5B, and 5D).
53Bp1/ MEFs reconstituted with full-length or BRCT-deleted
53BP1 protein fully restored RIF1 IRIF, while a 53BP1 mutant
protein N-terminally truncated adjacent to its oligomerization
motif (53BP1DN) or a mutant lacking both the N terminus and
BRCT domains (53BP1DNDC) could not, despite each readily
forming 53BP1 IRIF (Figures 5C and 5F).
The 53BP1 N terminus contains 28 S/TQ motifs, which are
known to be phosphorylated by the DSB-responsive kinase
ATM following IR. To determine if the ATM phospho-sites in the
N terminus of 53BP1 are important for RIF1 IRIF, we reconsti-
tuted 53Bp1/ MEFs with a smaller N-terminal truncation
mutant (53BP1619+), a 53BP1 mutant comprising alanine substi-
tutions of the 20 most N-terminal S/TQ motifs (53BP120AQ); and
a similar mutant but with the five most N-terminal S/TQ motifs
spanning the PTIP phospho-interaction motif (Ser25) left intact
(53BP115AQ; Figures 5A and 5D) (Munoz et al., 2007). Notably,
53Bp1/ MEFs reconstituted with 53BP1619+ recruited residual
RIF1 protein into some IRIF, yet thesewere substantially reduced
in number and intensity (Figures 5E and 5F). Strikingly, 53Bp1/
MEFs reconstituted with either 53BP120AQ or 53BP115AQ
mutants failed to recruit RIF1 into IRIF (Figures 5E and 5F).
The requirement for 53BP1 S/TQ phosphorylation in pro-
moting RIF1 recruitment to DSBs prompted us to test the
A B
C D
Figure 4. A Role for RIF1 in the Cellular Responses to DSBs
(A) WT and Rif1/MEFs were untreated (CNTL) or harvested at indicated times following g-irradiation before immunostaining with the indicated antisera. Zoom
panels correspond to indicated cells in left panels.
(B) gH2AX IRIF were scored in cells of indicated genotype 24 hr following mock treatment or IR at the indicated doses. Where indicated, cells were either mock
treated (DMSO) or incubated with ATMi (KU55933, 10 mM) from 30min before irradiation until harvesting. Mean number of gH2AX IRIF per cell is plotted ± SEM. n
> 200 cells/condition over two independent experiments.
(C) The survival of MEFs of indicated genotype following control or g-irradiation treatments was assessed by colony survival assay. n = 3 ± SEM.
(D) Measurement of NHEJ proficiency in HEK239 EJ5 cells subjected to the indicated siRNAs. n = 3 ± SEM unpaired two-tailed t test. See also Figure S5.
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reliance of RIF1 IRIF on ATM kinase activity. Indeed, ATMi treat-
ment severely compromised induction of RIF1 IRIF while
inducing a modest increase in 53BP1 IRIF (Figures 6A and 6B).
Consistent with previous findings (Buonomo et al., 2009), RIF1
foci apparent in both untreated and ATMi-treated irradiated cells
(Figure 6B) were found to be associated with heterochromatin
and not DSBs (Figure S6A).
Next, we sought to determine if phosphorylation of 53BP1 by
ATM promoted interaction with RIF1. To this end we immuno-
purified FLAG-HA-53BP1 and its FLAG-HA-53BP120AQ mutant
A
B
C
D
E F
Figure 5. RIF1 Recruitment to DNA Damage Sites Requires Phosphorylation of the of 53BP1 S/TQ Domain
(A) Schematic of 53BP1 mutants generated to examine the requirements for RIF1 IRIF. Numbers indicate N- and C-terminal 53BP1 residues for each truncation
mutant. Lines indicate relative positions of S/T residues in each S/TQ motif and whether they were either alanine-substituted (red) or left intact (blue) in each
respective mutant.
(B) Western blot demonstrating comparable expression of hemagglutinin (HA)-tagged 53BP1 mutants analyzed in (C) upon lentivirus-mediated reconstitution in
53Bp1/ cells.
(C) The ability of the indicated 53BP1 mutant to support RIF1 IRIF was examined by indirect immunofluorescence in irradiated cells 1 hr following IR.
(D) Western blot of the indicated 53BP1mutants reconstituted in 53Bp1/ cells and analyzed in (E) to examine the function of the 53BP1 N terminus and its S/TQ
ATM consensus phosphorylation in promoting RIF1 IRIF.
(E) Similar to (C) but with the indicated 53BP1 mutants reconstituted in 53Bp1/ cells. Arrowheads indicate colocalizing foci.
(F) Quantification of RIF1 and 53BP1 IRIF with the indicated 53BP1 mutants reconstituted in 53Bp1/ cells. n = 2, >140 cells scored per condition ± SEM.
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counterpart from reconstituted 53BP1/ cells before or after IR
treatment (Figures 6C and 6D). 53BP1 proteins were then incu-
bated in untreated nuclear extracts and examined for the ability
to bind RIF1. Strikingly, a robust interaction was only observed
between RIF1 and 53BP1 purified from IR-treated cells (Fig-
ure 6D). In contrast, the 53BP120AQ mutations compromised
RIF1 interaction (Figure 6D) and ATM inhibition also abolished
IR-induced interactions between RIF1 and WT 53BP1 (Figures
6E and 6F). Thus, ATM-dependent phosphorylation of 53BP1
is crucial for interaction with and recruitment of RIF1 to DSB sites
following DNA damage.
RIF1 Inhibits DSB Resection at IR-Induced DSBs
53BP1 performs a critical role in DSB repair pathway choice by
limiting the resection of DSBs induced by IR and during CSR
and V(D)J recombination (Bothmer et al., 2010, 2011; Difilippan-
tonio et al., 2008). Given our findings that 53BP1 and RIF1 are
both required for NHEJ, we investigated whether RIF1 is also
required to prevent 50-end resection. To this end, we exploited
the fact that RPA-ssDNA complexes, resulting from DSB resec-
tion, trigger ATR activation (Nam and Cortez, 2011). Further-
more, levels of RPA-ssDNA on 50-recessed DNA substrates
correlate with the degree of Chk1 phosphorylation on Ser345
(pChk1) by ATR (MacDougall et al., 2007). We therefore
reasoned that derepression of DSB resection in Rif1/ cells
might result in enhanced pChk1. Indeed, Rif1/MEFs exhibited
significantly elevated levels of pChk1 at all time points examined
following IR when compared toWT cells, while cell-cycle profiles
and phosphorylation kinetics of the ATM substrate Chk2
appeared comparable in WT and Rif1/ MEFs (Figures 7A
A B C
D E F
Figure 6. ATM-Dependent Phosphorylation of 53BP1 Promotes RIF1 Interaction
(A) Irradiated WT MEFs pretreated with DMSO or ATMi were fixed and immunostained for gH2AX and either RIF1 or 53BP1.
(B) Quantification of 53BP1 and RIF1 IRIF in cells prepared as in (A). n > 4 ± SD, >126 cells scored per condition.
(C) Immunoblots of whole-cell lysates prepared from 53Bp1/MEFs complemented with the indicated constructs as in Figure 5 1 hr following mock or 10 Gy IR.
(D) Flag-HA-53BP1 proteins were purified with Flag-M2 beads (Sigma) from lysates in (C) under stringent conditions. Bead complexes were subsequently
incubated in nuclear extracts (HNE) before 53BP1-associated proteins were recovered by peptide elution. B/O = beads-only control.
(E) Immunoblots of whole-cell lysates of 53Bp1/ MEFs complemented with WT 53BP1, 1 hr following mock or 15 Gy IR treatments in the presence/absence
of ATMi.
(F) As in (D), but with FLAG-HA-53BP1 purified from lysates indicated in (E). See also Figure S6.
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and S7A). Moreover, IR-induced pChk1 was also enhanced in
53Bp1/ MEFs (Figure 7B), consistent with its established
role in inhibiting resection. Importantly, the enhanced IR-induced
pChk1 levels in 53Bp1/ MEFs was rescued to WT levels by
full-length 53BP1, whereas 53Bp1/ MEFs reconstituted with
53BP1DN or 53BP120AQ, which are defective for RIF1 IRIF,
failed to suppress enhanced pChk1 levels in 53Bp1/ cells
(Figure 7C). Thus, 53BP1, its N-terminal phospho-SQ/TQ
sites, and RIF1 itself all contribute to the suppression of DSB
resection.
To further examine a role for RIF1 in blocking DSB resec-
tion, we also subjected WT, Rif1/, 53Bp1/, and Rif1/
53Bp1/ MEFs to IR treatment and then analyzed the levels
of RPA phosphorylation, an established marker of DSB resec-
tion (Sartori et al., 2007). Strikingly, RIF1- and 53BP1-deficient
cells exhibited markedly enhanced RPA phosphorylation after
IR treatment when compared to WT cells. Furthermore, RPA
phosphorylation was not further enhanced in Rif1/53Bp1/
cells when compared to Rif1/ and 53Bp1/ knockout cells
(Figure 7D).
RIF1 InhibitsDSBResection atDSBs InducedduringCSR
We reasoned that the observed defects in CSR detected in
Rif1/ lymphocytes might result from a failure to efficiently
repress the inappropriate nucleolytic processing of DSBs
induced during CSR. Indeed, the failure to switch isotype during
CSR in 53Bp1/ lymphocytes is associated with increased
nonproductive short-range recombination events within IgH
locus switch (S) regions mediated by repair of aberrantly pro-
cessed DSBs (Bothmer et al., 2010; Reina-San-Martin et al.,
2007). To examine if inappropriate processing of S-regions
might also occur in the absence of RIF1, WT and Rif1/
lymphocytes were either untreated or stimulated to class switch
in vitro and then subjected to chromatin immunoprecipitation
(ChIP) for total histone and RPA32. Similar histone ChIP signals
were observed between WT and Rif1/ lymphocytes at
a control locus (Rpp30) and within (Sm(a)) and proximal (Sm(b))
to the core Sm-region (Figure 7E). In contrast, analysis of
RPA32 ChIPs from WT and Rif1/ lymphocytes induced to
undergo CSR revealed striking differences in ChIP signals:
Rif1/ cells exhibited 10-fold increases in RPA32 residency
at both Sm loci when compared to WT, while comparable near
background RPA32 signals were evident at the Rpp30 control
locus in both cell types (Figures 7E and S7B). Importantly, the
induction of RPA32 ChIP signal at IgH loci in RIF1-deficient
lymphocytes was only evident upon B cell stimulation; unstimu-
lated cells exhibited near background signals. These data reveal
that RPA32 accumulates within the IgH switch region in switch-
ing RIF1-deficient cells, indicative of the aberrant resection of
CSR-induced DSBs.
DISCUSSION
RIF1 is one of a few proteins identified to date that requires
53BP1 for its recruitment to DSBs (Silverman et al., 2004). Never-
theless, a role for RIF1 as a potential 53BP1 cofactor has been
largely overlooked, in part due to the reported phenotypic differ-
ences of murinemodels of RIF1 and 53BP1 deficiency: RIF1 was
previously reported as essential for embryogenesis (Buonomo
et al., 2009), whereas 53Bp1/ animals are viable but radiosen-
sitive and immune-deficient (Manis et al., 2004; Ward et al.,
2003, 2004). Moreover, vertebrate RIF1 performs regulatory
roles during DNA replication that are not obviously shared with
53BP1 (Buonomo et al., 2009; Cornacchia et al., 2012; Xu
et al., 2010; Yamazaki et al., 2012), and RIF1 depletion/
disruption was reported to affect gene conversion frequencies
to different extents in different cell types (Buonomo et al.,
2009; Wang et al., 2009), which was also at odds with a role
for RIF1 in promoting 53BP1-dependent NHEJ.
Here we report that Rif1-deficient male mice are viable in
a specific genetic background. Although Rif1/ male mice are
superficially normal, they succumb to bacterial infections owing
to CSR defects comparable in severity to that previously re-
ported for 53BP1-deficient mice. Indeed, analysis of RIF1-defi-
cient MEFs revealed that RIF1 is essential for 53BP1-dependent
NHEJ. This assertion is based on our observation that, analo-
gous to 53BP1, unconstrained RIF1 activity both drives toxic
repair events in Brca1-deficient cells and mediates the NHEJ
of dysfunctional telomeres. RIF1-deficient cells also exhibit hall-
marks of defective DSB repair including IR sensitivity and de-
layed DSB resolution. Moreover, the fact that 53Bp1/Rif1/
double-knockout MEFs were found to be no more sensitive to
IR treatment than the Rif1/ single-knockout MEFs suggests
that RIF1 and 53BP1 function in the same genetic pathway.
The epistatic nature of RIF1, 53BP1, and double siRNA treat-
ments on NHEJ frequency in human cells reinforces this notion.
In this light, it is notable that a role for RIF1 during NHEJwas sug-
gested by previous work in the avian DT40 cells. In this setting,
RIF1 deficiency was accompanied by 2- to 4-fold increases in
gene-targeting frequencies (Xu et al., 2010), a characteristic
often used as a measure of HR proficiency in DT40, and whose
elevation is characteristic of NHEJ mutants including 53BP1-
knockout lines (Nakamura et al., 2006; Yamazoe et al., 2004).
Our analysis also establishes a mechanistic basis for RIF1-
53BP1 cooperation. Specifically, we find that the phosphor-
ylation of 53BP1 by ATM stimulates interaction with RIF1,
facilitating RIF1 targeting to DSBs. Thus, our findings provide
molecular insight to explain the importance of 53BP1 phosphor-
ylation, whose critical role in blocking DSB-resection and
promoting NHEJ during CSR and between uncapped telomeres
was previously unclear (Bothmer et al., 2011; Rai et al., 2010).
Unfortunately, RIF1’s domain architecture offers few clues into
how ATM-dependent phosphorylation of 53BP1 actually facili-
tates RIF1 interactions via phospho- or charge-specific interac-
tions. Nevertheless, as ATM signaling also promotes DSB
resection upon 53BP1 disruption (Bothmer et al., 2010; Bunting
et al., 2010), its direct stimulation of RIF1 recruitment to DSBs
might represent a molecular switch to suppress such activities
when 53BP1 is present at DSB sites.
Recent evidence suggests that 53BP1’s ability to establish an
effective barrier against DSB resection in G1 is intrinsic to its
NHEJ function (Bothmer et al., 2010, 2011; Bunting et al.,
2012; Difilippantonio et al., 2008). We find RIF1 is central to
this process, its deficiency enhancing ATR checkpoint signaling
in response to IR treatments, a feature suggestive of DSB hyper-
resection and mirrored by 53Bp1/, Rif1/ 53Bp1/, and
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Figure 7. RIF1 Represses DSB Resection Following IR and at the IgH Locus in Stimulated B Cells
(A and B) Enhanced ATR signaling in RIF1- and 53BP1-deficent cells. Lysates prepared fromWT,Rif1/, and 53Bp1/MEFs, harvested at indicated time points
following IR, were immunoblotted with indicated antisera.
(legend continued on next page)
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complemented cell lines defective in RIF1 recruitment. Finally,
RIF1’s role in blocking aberrant DSB processing is substantiated
by our findings that abnormally high levels of the ssDNA-binding
RPA32 protein accumulate at IgH S-regions in Rif1/ B cells
upon stimulation. Significantly, similar IgH-specific differ-
ences in RPA32 signal were recently reported between WT and
53Bp1/ B cells in ChIP-sequencing experiments (Bunting
et al., 2012; Hakim et al., 2012). Thus our data establish that
cooperative inhibition of DSB resection by 53BP1 and RIF1 is
crucial for NHEJ.
The function of 53BP1 in blocking DSB resection requires its
ability to oligomerize and bind the abundant histone H4
K20me2 epitope (Bothmer et al., 2011). Intriguingly, we found
that 53BP1 IRIF are diminished in intensity in Rif1/ cells (Fig-
ure 4A). Perhaps cooperative interactions between 53BP1 and
RIF1 act to stabilize a DSB-proximal chromatin state refractory
to access by nucleases and other DNA modifying enzymes,
thereby blocking DSB resection over large distances spanning
DSB ends. While many genetic observations in yeast attribute
resection inhibition largely to the dsDNA end-binding Ku-hetero-
dimer (Ku) (reviewed in Symington and Gautier, 2011), recent
evidence in mice indicates that 53BP1 asserts much more of
a repressive effect on this activity than Ku (Bunting et al.,
2012). Indeed, the fact that 53BP1 binds chromatin (and not
DNA ends) suggests that resection may actually be influenced
at a distance from DNA ends. Thus, establishment of a 53BP1-
RIF1-mediated chromatin barrier in the vicinity of DSBs may
ensure DSB end integrity is preserved, favoring NHEJ, and pre-
venting deleterious repair events. In addition to posing a barrier
to DSB resection, 53BP1 has also been attributed an ability to
increase the subnuclear mobility of dysfunction telomeres, an
activity proposed to increase the contact frequency of distally
position DSB ends and thus their ligation (Dimitrova et al.,
2008). Considering our observed role for Rif1 in promoting
telomere end-fusions, it will be intriguing to see if RIF1 also
contributes to this process.
Genetic observations in mice (Bothmer et al., 2011; Bunting
et al., 2010) led to the proposal that 53BP1 binding to chromatid
breaks in BRCA1-deficient cells interferes with HR by blocking
resection at the break site, which is required for HR-dependent
repair. To counteract an inhibitory activity toward DSB resection
in S phase, it was suggested that BRCA1 may act to displace
NHEJ factors from replication-associated DSBs, but evidence
to support this model was lacking (Bunting et al., 2010). We
recently showed that while 53BP1 forms foci at DSBs in G1
and S cell-cycle phases, it is excluded from the core of foci in
an S phase and BRCA1-dependent manner (Chapman et al.,
2012a). We proposed that the timely removal of 53BP1 from
the core of the focus in S phase relieves the barrier to DSB resec-
tion, allowing HR dependent repair to proceed. Intriguingly, we
now show that BRCA1 is also responsible for the downregulation
of RIF1 IRIF in both S and G2 cell-cycle phases, suggesting that
while this likely contributes to a switch from NHEJ to HR repair
modes during S phase, BRCA1 may also prevent excessive
RIF1/53BP1-depedent NHEJ in G2 in a similarmanner. Certainly,
an improved understanding of how 53BP1 and RIF1 cooperate
within their DSB-associated chromatin environment to inhibit
resection may be key to elucidating BRCA1’s molecular role in
counteracting such activities and defining the mechanisms of
DSB repair pathway choice. We anticipate future studies inves-
tigating RIF1’s regulatory roles in other nuclear contexts may
provide vital clues to understand how it facilitates productive
recombination events in lymphocytes and toxic repair events
that drive tumorigenesis.
EXPERIMENTAL PROCEDURES
Lymphocyte Methods and In Vitro CSR
B cells were purified by negative selection from single-cell suspensions from
spleen using magnetic separation B cell isolation kit (Miltenyi Biotec) accord-
ing to manufacturer’s instructions. Purified cells (purity > 95%) were cultured
for 3–6 days at 106 cells/ml in RPMI supplemented with 10% FCS and LPS
(10 mg/ml, Sigma), IL-4 (10 ng/ml, R&D), and/or anti-mouse CD40 antibody
(5 mg/ml; FGK45, Enzo Life Sciences). For proliferation analyses B cells were
labeled with 5 mM Cell Trace Violet (Molecular Probes) in PBS for 15 min at
37C before culture. For details of antibodies, ELISA, and flow cytometric
methods, see Supplemental Information.
Cell Culture, Transfection, and shRNA
E13.5 MEFs prepared and SV40 LargeT-immortalized by standard procedures
were used in all experiments unless otherwise indicated. HeLa and HEK293
cells were transfected with vector or siRNA using XtremeGene-HP (Roche)
and siRNA-MAX (Invitrogen) reagents, respectively, according to manufac-
turers’ instructions. NHEJ reporter assays in HEK293-EJ5 cells were per-
formed as previously described (Bennardo et al., 2008), with minor modifica-
tions (see Supplemental Information). Brca1-targeting shRNA oligos 1 (target
seq: CCAAGAAGAGGATAGTATAAT) and 2 (target seq: GTGCTTCCACACCC
TACTTAC) were cloned into pLKO.1-Puro plasmid (Addgene plasmid 10878),
and these or a control (empty vector) were used to generate lentivirus to deliver
shRNA. Viral supernatants were prepared as described (http://www.addgene.
org/plko), and frozen viruswas used to transduceMEFs in two sequential infec-
tions 12 hr apart, before selection in 2–3 mg/ml puromycin. Shelterin disruption
was achieved by retroviral transduction of pLPC-Myc-TRF2 and pLPC-Myc-
TRF2DBDM constructs as previously described (van Steensel et al., 1998).
Immunoprecipitation and Protein Interaction
Flag-HA-53BP1 protein was immunopurified on Flag-M2 agarose (Sigma),
from whole-cell lysates prepared as previously described (Chapman and
Jackson, 2008): washed in lysis buffer 3 2, in TSE-150 (see ChIP in Supple-
mental Information) 3 1, and in TSE-500 3 1 before equilibration in Dignam’s
buffer D (20 mM HEPES [pH 7.4], 20% glycerol, 0.1 M KCl, 1 mM EDTA,
0.1 mM EGTA, 1 mM DTT, protease inhibitors). Beads were then incubated
in HeLa nuclear extracts (CilBiotech.be) for >1 hr before multiple washes in
Buffer D. Immunocomplexes were eluted with triple-Flag peptide. For detailed
ChIP methods, see Supplemental Information.
(C) 53Bp1/ MEF lines reconstituted with indicated WT and mutant 53BP1 proteins (see also Figures 5A–5D) were examined for IR-induced checkpoint
phosphorylation events as in (A) and (B).
(D) Lysates prepared from WT, Rif1/, 53Bp1/, and Rif1/53Bp1/ MEFs harvested 3 hr following IR were immunoblotted with indicated antisera.
(E) Aberrant processing of the IgH locus in Rif1/ cells. Schematic of IgH Sm region shows relative positions of qPCR amplicons used in ChIP experiments. A
control non-IgH locus (Rpp30) was also examined. Resting B cells or those stimulated with LPS and IL-4 (72 hr) were subjected to ChIP experiments with IgG
(control), histone H2A.X, and RPA32 monoclonal antisera. Following background subtraction of IgG signals, values were normalized to the DNA input signals,
followed by the maximum value in each data set. Mean signals, two independent experiments ± SEM. See also Figure S7.
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SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.molcel.2013.01.002.
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